NervGen Pharma
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| NVG-291 in Spinal Cord Injury Subjects (NCT05965700) | NervGen Pharma | 2023-08-08 |
| A Phase I Safety Study of NVG-291 in Healthy Adults (NCT05308953) | NervGen Pharma | 2021-05-06 |
Track NervGen Pharma automatically
Every clearance here is in the API, with alerts when new ones post.